Text Size

Quality of life measures and health utility values among dry eye subgroups

Shigeyasu C., Yamada M., Kawashima M., Suwaki K., Uchino M., Hiratsuka Y., Yokoi N., Tsubota K., Shigeyasu C., Yamada M., Kawashima M., Suwaki K., Uchino M., Hiratsuka Y., Yokoi N., Tsubota K., Tagawa Y., Den S., Iwasaki M., Saito H., Ishida R., Komuro A., Iwasaki N., Matsumoto H., Goto T., Kiyosawa A., DECS-J study group


  • 2018
  • Health and Quality of Life Outcomes
View publication
  • Therapeutic Area

    Front of the eye (FOTE)

  • Categories

    Disease understanding (epidemiology, diagnosis, QoL, Biomarkers…)

  • Affiliations

    Kyorin University School of Medicine, Department of Ophthalmology, Tokyo, Japan; Keio University School of Medicine, Department of Ophthalmology, Tokyo, Japan; Santen Pharmaceutical Co., Ltd, Osaka, Japan; Juntendo University Graduate School of Medicine, Department of Ophthalmology, Tokyo, Japan; Kyoto Prefectural University of Medicine, Department of Ophthalmology, Kyoto, Japan; Kitaichijo Tagawa Eye Clinic, Sapporo, Hokkaido, Japan; Akasaka Tokyu Shimazaki Eye Clinic, Tokyo, Japan; Ryogoku Eye Clinic, Tokyo, Japan; Saito Eye Clinic, Saitama, Japan; Ishida Clinic, Shizuoka, Japan; Shijokarasuma Komuro Eye Clinic, Kyoto, Japan; Iwasaki Eye Clinic, Osaka, Japan; Matsumoto Eye Clinic, Tokushima, Japan; Hanamizuki Eye Clinic, Ehime, Japan; Kiyosawa Eye Clinic, Fukuoka, Japan

Related Publications

Burden of Vernal Keratoconjunctivitis in the United States: A Retrospective Claims Database Analysis

Koo E.B.; Yu T.M.; Layton A.J.; Babineaux S.; Fung S.


Review of clinical outcomes of a cationic emulsion tear substitute in patients with dry eye disease

Labetoulle M, Garhöfer G, Ismail D, Garrigue JS, Amrane M, Guillon M, Aragona P, Baudouin C.


Epinastine Cream: A Novel Once-Daily Therapeutic Agent for Allergic Conjunctivitis

Ogura N., Fujisawa K., Kato M.


Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022